JP2015510883A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015510883A5 JP2015510883A5 JP2014561022A JP2014561022A JP2015510883A5 JP 2015510883 A5 JP2015510883 A5 JP 2015510883A5 JP 2014561022 A JP2014561022 A JP 2014561022A JP 2014561022 A JP2014561022 A JP 2014561022A JP 2015510883 A5 JP2015510883 A5 JP 2015510883A5
- Authority
- JP
- Japan
- Prior art keywords
- aureus
- vaccine
- infection
- biofilm
- days
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261606750P | 2012-03-05 | 2012-03-05 | |
| US61/606,750 | 2012-03-05 | ||
| PCT/US2013/029053 WO2013134225A1 (en) | 2012-03-05 | 2013-03-05 | Multivalent vaccine protection from staphylococcus aureus infection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015510883A JP2015510883A (ja) | 2015-04-13 |
| JP2015510883A5 true JP2015510883A5 (https=) | 2016-04-21 |
| JP6204930B2 JP6204930B2 (ja) | 2017-09-27 |
Family
ID=49117246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014561022A Expired - Fee Related JP6204930B2 (ja) | 2012-03-05 | 2013-03-05 | 多価ワクチンによる黄色ブドウ球菌感染症からの保護 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | USRE48137E1 (https=) |
| EP (1) | EP2822582B1 (https=) |
| JP (1) | JP6204930B2 (https=) |
| CA (1) | CA2865620A1 (https=) |
| ES (1) | ES2642892T3 (https=) |
| WO (1) | WO2013134225A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5548121B2 (ja) | 2007-05-14 | 2014-07-16 | リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク | バイオフィルム中の細菌細胞における生理学的分散応答の誘導 |
| US20170049848A1 (en) * | 2014-05-06 | 2017-02-23 | Virginia Commonwealth University | Target for Firmicutes and Related Bacteria: The PRP Protease |
| CN110402145A (zh) | 2016-10-26 | 2019-11-01 | 莫得纳特斯公司 | 用于增强免疫应答的信使核糖核酸及其使用方法 |
| JP2020512308A (ja) * | 2017-03-31 | 2020-04-23 | アセル，インコーポレイテッド | 細菌性感染症の患者を保護および治療するのに有用な、殺菌特性または静菌特性を有する細胞外基質組成物 |
| AU2018379996A1 (en) | 2017-12-05 | 2020-06-25 | BioPlx, Inc. | Methods and compositions to prevent microbial infection |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| WO2022155421A1 (en) * | 2021-01-15 | 2022-07-21 | University Of Rochester | Staphylococcus aureus antigen-based nucleic acid vaccines |
| CN112940987B (zh) * | 2021-04-10 | 2022-10-14 | 福建省农业科学院畜牧兽医研究所 | 一株兔金黄色葡萄球菌及其在制备灭活疫苗中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0107661D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
| AU2003278714A1 (en) | 2002-08-20 | 2004-03-11 | Chiron Corporation | Random transposon insertion in staphylococcus aureus and use thereof to identify essential genes |
| EP2476433A1 (en) * | 2006-03-30 | 2012-07-18 | GlaxoSmithKline Biologicals S.A. | Immunogenic composition |
| CA2694974C (en) | 2007-07-30 | 2016-11-08 | University Of Maryland, Baltimore | Methods and devices for the detection of biofilm |
| US8318180B2 (en) | 2008-09-30 | 2012-11-27 | University Of Maryland, Baltimore | Protective vaccine against Staphylococcus aureus biofilms comprising cell wall-associated immunogens |
-
2013
- 2013-03-05 WO PCT/US2013/029053 patent/WO2013134225A1/en not_active Ceased
- 2013-03-05 ES ES13757330.9T patent/ES2642892T3/es active Active
- 2013-03-05 JP JP2014561022A patent/JP6204930B2/ja not_active Expired - Fee Related
- 2013-03-05 US US15/903,831 patent/USRE48137E1/en active Active
- 2013-03-05 US US14/382,837 patent/US9265820B2/en not_active Ceased
- 2013-03-05 CA CA2865620A patent/CA2865620A1/en not_active Abandoned
- 2013-03-05 EP EP13757330.9A patent/EP2822582B1/en not_active Not-in-force
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015510883A5 (https=) | ||
| JP6204930B2 (ja) | 多価ワクチンによる黄色ブドウ球菌感染症からの保護 | |
| RU2020133461A (ru) | Предотвращение, разрушение и обработка биопленки лизином бактериофага | |
| Gomes et al. | Control of bovine mastitis: old and recent therapeutic approaches | |
| RU2018107249A (ru) | Применение лизина для восстановления/увеличения антибактериальной активности антибиотиков в присутствии легочного сурфактанта, который ингибирует указанные антибиотики | |
| Brunel et al. | Multidrug resistant (or antimicrobial-resistant) pathogens-alternatives to new antibiotics? | |
| NZ612315A (en) | Compositions for immunising against staphylococcus aureus | |
| JP2017519768A5 (https=) | ||
| RU2014134720A (ru) | Противомикробные композиции, содержащие dgla, 15-онера и/или 15-hetre, и способы их применения | |
| FI3006038T3 (fi) | Oritavansiinin yksittäisannokset bakteeri-infektion hoitoon tai ehkäisyyn | |
| JP2012501349A5 (https=) | ||
| EP2344189B1 (en) | Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens | |
| WO2013032964A1 (en) | Compositions and methods for preventing and treating biofilms | |
| EA202290048A1 (ru) | Лекарственное средство и его применение для лечения бактериальных инфекций, связанных с биопленкой | |
| Gelalcha et al. | Antimicrobial usage for the management of mastitis in the USA: impacts on antimicrobial resistance and potential alternative approaches | |
| Malu et al. | Topical use of citric acid for wound bed preparation | |
| PH12019500242A1 (en) | 9-aminomethyl minocycline compounds and uses thereof | |
| MX366894B (es) | Composiciones antimicrobianas y métodos para su producción. | |
| WO2013042140A2 (en) | Non antibiotic,non peptide compounds for antibiotic efficacy & safety enhancement | |
| Aqib et al. | Dairy Staphylococcus aureus: Epidemiology, drug susceptibilities, drug modulation, and preventive measures | |
| JP2008526848A (ja) | 黄色ブドウ球菌感染を治療する方法 | |
| Lew et al. | Ofloxacin solution for persistent exit-site and tunnel infection in peritoneal dialysis | |
| Ko et al. | Host-pathogen interactions in urinary tract infections | |
| MX2021012375A (es) | Metodo para tratar y prevenir infecciones oseas y de articulaciones. | |
| US20260000736A1 (en) | Purified lactoferrin compositions and methods of use |